Progress Toward Measles Elimination — European Region, 2009–2018

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Personal Author:
  Zimmerman, Laura A. ; Muscat, Mark ; Singh, Simarjit ; Ben Mamou, Myriam ; Jankovic, Dragan ; Datta, Siddhartha ; Alexander, James P. ; Goodson, James L. ; O’Connor, Patrick
• Description:
  In 2010, all 53 countries* in the World Health Organization (WHO) European Region (EUR) reconfirmed their commitment to eliminating measles and rubella and Congenital rubella syndrome (1); this goal was included as a priority in the European Vaccine Action Plan 2015-2020 (2). The WHO-recommended elimination strategies in EUR include 1) achieving and maintaining ≥95% coverage with 2 doses of measles-containing vaccine (MCV) through routine immunization services; 2) providing measles and rubella vaccination opportunities, including supplementary immunization activities (SIAs), to populations susceptible to measles or rubella; 3) strengthening Surveillance by conducting case investigations and confirming suspected cases and outbreaks with laboratory results; and 4) improving the availability and use of evidence for the benefits and risks associated with vaccination (3). This report updates a previous report (4) and describes progress toward measles elimination in EUR during 2009-2018. During 2009-2017, estimated regional coverage with the first MCV dose (MCV1) was 93%-95%, and coverage with the second dose (MCV2) increased from 73% to 90%. In 2017, 30 (57%) countries achieved ≥95% MCV1 coverage, and 15 (28%) achieved ≥95% coverage with both doses. During 2009-2018, >16 million persons were vaccinated during SIAs in 13 (24%) countries. Measles incidence declined to 5.8 per 1 million population in 2016, but increased to 89.5 in 2018, because of large outbreaks in several EUR countries. To achieve measles elimination in EUR, measures are needed to strengthen immunization programs by ensuring ≥95% 2-dose MCV coverage in every district of each country, offering supplemental measles vaccination to susceptible adults, maintaining high-quality Surveillance for rapid case detection and confirmation, and ensuring effective outbreak preparedness and response.
• Subjects:
  Child Child, Preschool Disease Eradication Disease Outbreaks Full Report Genotype Humans Immunization Programs Immunization Schedule Incidence Infant Measles Measles Vaccine Measles Virus Population Surveillance Vaccination Coverage

  More +
• Source:
  MMWR Morbidity Mortal Weekly Rep. 68(17):396-401
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• DOI:
  http://dx.doi.org/10.15585/mmwr.mm6817a4
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  31048675
• Pubmed Central ID:
  PMC6541314
• Document Type:
  Journal Article
• Place as Subject:
  Europe
• Pages in Document:
  6 pdf pages
• Volume:
  68
• Issue:
  17
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:bdf26805d4f6a7c1ecbe6ab75e5b44c848e6d0fd7b292e64d67dc2f7cf684e470d4b8b4e5030691ef5529245c2a6ca098be92a36ebfd3c629dcf5f44e7376ddf
• Download URL:
  https://stacks.cdc.gov/view/cdc/78929/cdc_78929_DS1.pdf
• File Type:
  [PDF - 145.39 KB ]